News room

Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment

Start News Corporate Information General meeting

Press releases

Regulatory

May 30, 2022

Bulletin from Egetis Therapeutics’ Annual General Meeting 2022

Regulatory

April 13, 2022

Bulletin from extraordinary shareholders’ meeting in Egetis Therapeutics AB and publication of timetable relating to the rights issue

Regulatory

March 21, 2022

NOTICE OF EXTRAORDINARY GENERAL MEETING IN EGETIS THERAPEUTICS

Regulatory

April 29, 2021

Bulletin from Egetis Therapeutics’ Annual General Meeting 2021

Regulatory

December 11, 2020

Resolutions from extraordinary general meeting in PledPharma AB (publ) held on 11 December 2020

Regulatory

November 10, 2020

NOTICE TO ATTEND EXTRAORDINARY GENERAL MEETING IN PLEDPHARMA AB

Regulatory

October 28, 2020

Resolutions from extraordinary general meeting in PledPharma AB (publ) held on 28 October 2020

Regulatory

October 5, 2020

Notice of Extraordinary general meeting in PledPharma AB

Regulatory

April 23, 2020

Kommuniké från årsstämman i PledPharma AB (publ)

Regulatory

March 25, 2020

KALLELSE TILL ÅRSSTÄMMA I PLEDPHARMA AB

Share

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@egetis.com